Get Expert Advice for controlling your Severe Allergies

Cetiri D

Generic Name: cetirizine hydrochloride and pseudoephedrine hydrochloride
Dosage Form: tablet, extended release

Rite Aid Corporation Cetiri-D Drug Facts

Active ingredient (in each extended release tablet)

Cetirizine HCl 5 mg

Pseudoephedrine HCl 120 mg

Slideshow: 2014 Update: First Time Brand-to-Generic Switches

Purpose

Antihistamine

Nasal Decongestant

Uses

  • temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
  • runny nose
  • sneezing
  • itchy, watery eyes
  • itching of the nose or throat
  • nasal congestion
  • reduces swelling of nasal passages
  • temporarily relieves sinus congestion and pressure
  • temporarily restores freer breathing through the nose

Warnings

Do not use

  • if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.
  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

  • heart disease
  • thyroid disease
  • diabetes
  • glaucoma
  • high blood pressure
  • trouble urinating due to an enlarged prostate gland
  • liver or kidney disease. Your doctor should determine if you need a different dose.

Ask a doctor or pharmacist before use if you are

taking tranquilizers or sedatives.

When using this product

  • do not use more than directed
  • drowsiness may occur
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinery

Stop use and ask a doctor if

  • an allergic reaction to this product occurs. Seek medical help right away.
  • you get nervous, dizzy, or sleepless
  • symptoms do not improve within 7 days or are accompanied by fever

If pregnant or breast-feeding:

  • if breast-feeding: not recommended
  • if pregnant: ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.


Directions

  • do not break or chew tablet; swallow tablet whole
adults and children 12 years and over take 1 tablet every 12 hours; do not take more than 2 tablets in 24 hours.
adults 65 years and over ask a doctor
children under 12 years of age ask a doctor
consumers with liver or kidney disease ask a doctor

Other information

  • store between 20° to 25°C (68° to 77°F)

Inactive ingredients

colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, talc, yellow iron oxide

Questions or comments?

1-800-719-9260

Principal Display Panel

Compare to the Active Ingredients of Zyrtec-D®

Original Prescription Strength

Cetiri-D

Cetirizine Hydrochloride and

Pseudoephedrine Hydrochloride

Extended Release Tablets

5 mg/120 mg

antihistamine/nasal decongestant

Allergy & Congestion

Indoor & Outdoor Allergies

Actual Size

12 Hour

12 Hour Relief Of

Sneezing

Itchy, Watery Eyes

Runny Nose

Itchy Throat or Nose

Sinus Pressure

Nasal Congestion

Cetiri-D Carton

Cetiri D 
cetirizine hcl, pseudoephedrine hcl tablet, extended release
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:11822-0176
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CETIRIZINE HYDROCHLORIDE (CETIRIZINE) CETIRIZINE HYDROCHLORIDE 5 mg
PSEUDOEPHEDRINE HYDROCHLORIDE (PSEUDOEPHEDRINE) PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg
Product Characteristics
Color WHITE (one side white one side light yellow) Score no score
Shape ROUND Size 12mm
Flavor Imprint Code 5029;5;120
Contains         
Packaging
# Item Code Package Description
1 NDC:11822-0176-1 2 BLISTER PACK (BLISTER PACK) in 1 CARTON
1 6 TABLET, EXTENDED RELEASE (TABLET) in 1 BLISTER PACK
2 NDC:11822-0176-2 4 BLISTER PACK (BLISTER PACK) in 1 CARTON
2 6 TABLET, EXTENDED RELEASE (TABLET) in 1 BLISTER PACK
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA077170 04/10/2008
Labeler - Rite Aid Corporation (014578892)
Revised: 06/2009
 
Rite Aid Corporation



Hide
(web3)